Seventure Partners is a French venture capital firm targeting in Tech/Digital and Life Sciences companies. It funds innovation and participates in the entrepreneurial adventure, alongside entrepreneurs and sharing their passion. Founded in 1997, Seventure Partners is one of the European leaders in venture capital, with € 1 billion under management as of December 31, 2023. It is an active partner of innovative companies that, according to the management team, show strong growth potential and evolving in two fields of activity: Digital Technologies and Life Sciences. With more than 20 employees, including some 15 investors, Seventure Partners has a proven track record and in-depth expertise in technology, entrepreneurship, and various private equity operations. Seventure's goal is to identify and support the development of tomorrow's European leaders in order to accelerate their growth. To do this, the firm provides entrepreneurs with the expertise, networks, and know-how of its internal team of investors. The different funds/verticals on which Seventure Partners are focusing on today: - Life Sciences : Biotech, Healthcare, Nutrition - Tech/Digital : B2B SaaS, Fintech, Retailtech, Cybersecurity - Sports & Wellbeing - Blue Economy

Seventure Partners

Collaborative Fund is an investment fund that provides funding to companies based on creativity and collaborative consumption. The fund centers around two macro themes which drives business innovation in the coming years: the growth of the creative class and the concept of collaborative consumption. Craig Shapiro founded it in New York in 2010.

Collaborative Fund

From spiraling healthcare costs, to the rise of chronic diseases, to feeding a growing global population, the world is facing a complex web of interrelated challenges. iSelect was created to help solve these problems, connecting investors with the innovative companies that are fixing the food and health systems while opening up access to investment opportunities that are making a real impact on the future of our world.

iSelect Fund

Driven by a mission to redefine food, Acre invests in companies creating systemic change in the food system to address the growing problems of human and environmental health. Acre makes venture-stage investments in highly disruptive platform businesses across the food value chain, with a particular focus on the agriculture, food tech, and consumer verticals. Taken together, these investments have the ability to form the foundation of an integrated new approach to food system evolution.

Acre Venture Partners

Skyviews Life Science is a privately held advisory company specializing in personalized health. Skyviews Life Science identifies investment opportunities in companies at the growing interface between biotechnology, advanced nutrition, and digital health. Skyviews Life Science focuses in private and public companies with better drugs, advanced technology platforms, preventive strategies, personalized solutions, and more natural foods that will improve people’s quality of life.

Skyviews Life Science

Alpha Edison is a venture capital firm that focuses on technology-driven innovation. The firm helps entrepreneurs to build a better world. Alpha Edison is an early-stage venture firm that partners with courageous entrepreneurs to build industry-changing technology platforms. It helps founders to create new markets, unlock latent demand, and scale businesses by sharing its research and expertise in business model innovation.

Alpha Edison

Morado Ventures is focused on high-growth, seed-stage technology companies, with particular emphasis on “Data-fueled” businesses. The firm currently invests in Artificial Intelligence, Data Infrastructure, Industrial Internet, Robotics & Autonomy, Computer Vision, and Health. Morado Ventures was founded in 2010 and is based in Palo Alto, California, United States.

Morado Ventures

Leaps by Bayer invests in paradigm-shifting advances in the life sciences and specializes in the fields of biotechnology, agriculture, and scientific breakthrough. The firm's approach is making significant and sustained investments in disruptive biotechnologies that could have the greatest impact on humanity. It was founded in 2015 and headquartered in Leverkusen, Nordrhein-Westfalen.

Leaps by Bayer

Early-Stage Fund backing the future of Food & Sustainability

Great Circle Ventures

ReMY Investors & Consultants provides investment advisory and related services to ultra-high net worth families. ReMY provides specialist private equity investments to its clients, as well as intelligent asset allocation, manager selection, and investment performance monitoring.

ReMY

E12 Ventures is a new venture capital firm ,subsidiary of Mitsui & Co., Ltd., and Morado Ventures LLC.

E12 Ventures

DSM-Firmenich Venturing provides venture capital finance for startup firms.

DSM-Firmenich Venturing

one.bio

one.bio is a fast-paced, emerging biotechnology spinout from UC Davis creating ingredients for food and biopharmaceutical applications. We use proprietary technology to create novel oligosaccharides from natural products, with a focus on producing ingredients that beneficially modulate the microbiome and immune function.

One.bio is a company focused on advancing the understanding and utilization of fibers in human nutrition. The company has developed a unique mass spectrometry capability that has enabled them to build an extensive database of thousands of natural fiber compositions. This technology allows for a more comprehensive analysis of how fibers interact with the gut microbiome, which the company refers to as the "body's pharmacy." One.bio's work is part of what they consider a second wave of scientific understanding of fibers, moving beyond the traditional focus on vitamins and minerals that interact directly with the human body. The company's research aims to provide a more detailed understanding of how to nourish the microbiome that humans host and depend upon. One.bio's initial work began with infant nutrition, developing a formula that significantly reduced infant mortality. Building on this foundation, the company has expanded its focus to explore how their discoveries can be applied to improve health and well-being across all age groups.

Delivering health and powering your body’s pharmacy

One BIO

Unlocking nature's benefits for elevated wellness

Functional Nutrition Ingredients

One.bio is a company focused on advancing the understanding and utilization of fibers in human nutrition. The company has developed a unique mass spectrometry capability that has enabled them to build an extensive database of thousands of natural fiber compositions. This technology allows for a more comprehensive analysis of how fibers interact with the gut microbiome, which the company refers to as the "body's pharmacy." One.bio's work is part of what they consider a second wave of scientific understanding of fibers, moving beyond the traditional focus on vitamins and minerals that interact directly with the human body. The company's research aims to provide a more detailed understanding of how to nourish the microbiome that humans host and depend upon. One.bio's initial work began with infant nutrition, developing a formula that significantly reduced infant mortality. Building on this foundation, the company has expanded its focus to explore how their discoveries can be applied to improve health and well-being across all age groups.

One.bio is a company focused on advancing the understanding and utilization of fibers in human nutrition. The company has developed a unique mass spectrometry capability that has enabled them to build an extensive database of thousands of natural fiber compositions. This technology allows for a more comprehensive analysis of how fibers interact with the gut microbiome, which the company refers to as the "body's pharmacy." One.bio's work is part of what they consider a second wave of scientific understanding of fibers, moving beyond the traditional focus on vitamins and minerals that interact directly with the human body. The company's research aims to provide a more detailed understanding of how to nourish the microbiome that humans host and depend upon. One.bio's initial work began with infant nutrition, developing a formula that significantly reduced infant mortality. Building on this foundation, the company has expanded its focus to explore how their discoveries can be applied to improve health and well-being across all age groups.&nbsp;

Certified Nutraceuticals specializes in developing bio-active ingredients for foods, beverages, and supplements. The company holds 16 US patents for ingredients and extraction processes related to pomegranate, olive leaf, grapevine extracts, and jellyfish collagen. The company pioneered the introduction of Collagen Types I, II, and III as nutritional supplements and developed three collagen ingredients: KollaGen II-xs, kollaGen I.V.X.HEM, and TendoGuard Joint and Tendon Support, which contains collagen types I, II, V, and X. In 2001, the company patented a unique method to extract collagen from chicken sternums, used in products for joint pain relief and mobility restoration. Their ingredients support healthy aging, joint health, brain health, and cognitive function. The company's manufacturing processes comply with Fair Trade criteria, eco and dietary regulations, FDA guidelines, and Kosher and Halal requirements. All products undergo analysis in accordance with the Federal Drug Administration and Cosmetics Act and the Fair Packaging and Labelling Act. The company provides comprehensive services from initial product development to manufacturing, filling, and product launch, including logistics and disposition.
Key customers and partnerships
The company maintains an international network of distributors, wholesalers, and manufacturing partners. Among these partnerships is a collaboration with Nutraceuticals Agriceuticals Technology Company (NATCO), a leading supplier of organic monk fruit and persimmons, which operates farms and factories in Guilin, China.

Certified Nutraceuticals

Nupromic is a biotechnology company that specializes in developing functional ingredients and next-generation nutraceutical products for the food industry. The company operates Mexico's first Beta Glucan production facility and manufactures differentiated ingredients used in fortified food production.

Nupromic

Beneo is a manufacturer of functional ingredients derived from natural sources including chicory root, sugar beet, rice, and wheat for food, feed, and pharmaceutical products. The company specializes in producing functional carbohydrates, fibers, and proteins that improve nutritional and technical properties of various products. Its portfolio includes Isomalt and Palatinose (sugar beet-derived carbohydrates), Orafti Inulin and Oligofructose (chicory root fibers), and wheat and rice proteins. These ingredients are used across multiple applications including dairy, confectionery, bakery, cereals, baby food, and beverages to enhance taste, texture, and nutritional benefits. In May 2022, Beneo acquired Meatless B.V., a Dutch supplier of textured plant-based ingredients, expanding its capabilities in meat and fish alternatives. The company has six production facilities located in Belgium, Chile, Germany, Italy, and the Netherlands. Beneo invested EUR 7.7 million in March 2022 to quadruple storage capacity at its Offstein, Germany facility with a new automated warehouse capable of storing over 8,500 pallets. In 2022, the company also announced a EUR 50 million investment in a new fava bean processing plant in Offstein to produce protein concentrates, starch-rich flour, and hulls, scheduled for completion in late 2024.

Beneo

AlgaeCytes is a biotechnology company specializing in the cultivation of algae to produce health and wellness ingredients. The company utilizes an advanced photobioreactor system for algae cultivation, featuring enclosed glass tubing and LED lighting to stimulate photosynthesis. AlgaeCytes' patented process optimizes the photosynthetic process, allowing microalgae to flourish and produce valuable compounds. The system regulates light, nutrient supply, and temperature, enabling efficient and consistent production year-round, regardless of external weather conditions.
The company's primary focus is on producing omega-3 oils from microalgae as an alternative to fish-derived sources. This approach offers several advantages, including suitability for vegetarian diets, reduced pressure on fish stocks, and the ability to avoid potential contamination with trace heavy metals sometimes found in fish oil supplements. AlgaeCytes' method allows for the production of high-quality omega-3 oils with variable EPA:DHA ratios, catering to different formulation requirements.
In February 2018, AlgaeCytes joined the ProFlow consortium, which secured an Innovate UK grant of nearly GBP 630,000 for a two-year development program. The consortium aims to scale up a novel acoustic cell harvesting technology developed by LabXero, which could significantly reduce the costs associated with separating algal biomass from its culture medium. This technology uses resonant sound waves to create an acoustic barrier, separating water from microalgae without the need for energy-intensive centrifugation techniques. The development of this technology could potentially lower downstream processing costs, which constitute a substantial portion of total processing expenses in algae-based omega-3 production.

AlgaeCytes

Seed Health is a microbiome science company founded in 2015 by Ara Katz and Raja Dhir. The company focuses on developing probiotics and living medicines to impact both human and planetary health. Seed Health's flagship product is DS-01, a daily synbiotic (probiotic + prebiotic) supplement formulated with 24 clinically studied bacterial strains targeting digestive, cardiovascular, dermatological, and immune health. In May 2024, the company launched vs.-01, a vaginal synbiotic clinically validated to establish an optimal vaginal microbiome dominated by Lactobacillus crispatus.
Seed Health utilizes a full-stack platform that encompasses discovery, product development, and clinical research. The company employs bioinformatics and computational analyses to interrogate the role of the microbiome in overall health and design targeted probiotics. In April 2024, Seed Health introduced CODA, a computational biology platform powered by the Human Phenotype Project, which integrates over three million phenotypic data points from more than 13,000 individuals. This platform aims to develop next-generation precision probiotics and microbiome-directed interventions for areas including metabolic health, brain health, menopause, and longevity.
The company's research extends beyond human health to environmental applications through its SeedLabs division. This includes developing probiotics for honeybees to enhance their resilience against climate change-related stressors, as well as exploring microbial solutions for plastic degradation and soil health. Seed Health collaborates with leading scientists and research institutions to advance its work across various health domains, including vaginal health, skin health, oral hygiene, pediatrics, mental health, and nutrition.
Key customers and partnerships
The company has established partnerships with several academic and research institutions to further its scientific endeavors. In 2023, Seed Health announced a collaboration with the Swiss Institute of Allergy and Asthma Research (SIAF) to develop non-toxic, microbiome-safe home and personal care products. The company also partnered with Axial Therapeutics in 2022 to launch a Gut-Brain Development Program, focusing on translating research from Caltech into probiotic innovations for neuropsychiatric health.

Seed Health

Live beneficial microorganisms and non-digestible fibers to promote a balanced gut microbiome and improve digestive health

Plant-based extracts, fibers, and herbal ingredients with health-promoting properties like anti-inflammatory, adaptogenic, and antioxidant effects

Essential fatty acids and structured lipids such as omega-3 and amino acids that support heart health, cognitive function, and energy metabolism

Small protein fragments with targeted biological activities, such as boosting immunity, improving cardiovascular health, and reducing inflammation

Essential micronutrients and compounds that support improved immune system function, bone health, hair, and skin, among others

one.bio

Sources

About EDGE

Contact Us

Resources

Area of focus

Technology Research Made Effortless